Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
EVION GROUP NL | BAPA | Apr 17, 2025 | 0.01 | -37.50 |
Eviso SPA | 6Z8 | Apr 17, 2025 | 9.26 | -2.94 |
EVLI OYJ B | V6O | Apr 17, 2025 | 17.80 | -1.66 |
EVN AG | EVN | Apr 17, 2025 | 21.80 | +2.83 |
Evolent Health, Inc Class A | 9EH | Apr 17, 2025 | 8.05 | -5.85 |
Evolus, Inc. | EVL | Apr 17, 2025 | 8.85 | -1.12 |
Evolution | E3G1 | Apr 17, 2025 | 75.00 | +3.85 |
Evolution Energy Minerals Ltd | P77 | Apr 17, 2025 | 0.00 | 0.00 |
Evolution Mining Limited | WE7 | Apr 17, 2025 | 4.68 | +2.41 |
Evolution Petroleum Corporation, Inc. | EP7 | Apr 17, 2025 | 3.74 | +1.08 |
EVONIK INDS AG American Depositary Receipts - Unsponsored ( | EVKA | Apr 17, 2025 | 8.95 | +0.56 |
Evonik Industries AG | EVK | Apr 17, 2025 | 18.71 | -0.37 |
Evotec SE | EVT | Apr 17, 2025 | 6.37 | +8.27 |
EVOTEC SE ADR/2 O.N. | EVTA | Apr 17, 2025 | 2.98 | +2.76 |
EVRIMA PLC LS-,001 | 79R | Apr 17, 2025 | 0.00 | 0.00 |
EVS Broadcast Equipment SA | 5E1 | Apr 17, 2025 | 34.20 | -4.47 |
Exact Sciences Corporation | EXK | Apr 17, 2025 | 37.20 | -4.47 |
EXACT Therapeutics | 56F | Apr 17, 2025 | 0.21 | 0.00 |
Exagen Inc. | E08A | Apr 17, 2025 | 3.88 | -3.00 |
EXASOL AG NA O.N. | EXL | Apr 17, 2025 | 3.06 | +10.07 |
Excellence SA | 8XY | Apr 17, 2025 | 0.03 | +1.16 |
Excellon Resources Inc | E4X2 | Apr 17, 2025 | 0.09 | +18.42 |
Exchange Income Corp | 0ON | Apr 17, 2025 | 30.60 | -2.55 |
Exclusive Networks SA | 97K | Apr 17, 2025 | 18.88 | 0.00 |
EXCO Technologies Ltd. | 3XT | Apr 17, 2025 | 3.48 | +0.58 |
Exedy Corporation | 64M | Apr 17, 2025 | 24.00 | +1.69 |
EXEL COMPOSITES OYJ | 8TY | Apr 17, 2025 | 0.35 | -0.86 |
Exel Industries | 8YK | Apr 17, 2025 | 34.70 | -1.14 |
Exelixis, Inc. | EX9 | Apr 17, 2025 | 31.66 | +1.38 |
Exelon Corporation | PEO | Apr 17, 2025 | 40.91 | -0.51 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.